{"version":"1.0","type":"link","title":"Venetoclax and azacitidine versus CAG for unfit patients with newly diagnosed acute myeloid leukemia: A propensity score-matched analysis.","author_name":"Chang G 외","author_url":"https://prs-insight.online/author/Chang%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/159334","thumbnail_width":1200,"thumbnail_height":630}